Market Cap | 153.52K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -120.4k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 1.00% |
Sales | 13.5k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -6.00% |
Dividend | N/A | Price/Book | 2.60 | EPS next 5Y | - | 52W High Chg | -81.00% |
Recommedations | - | Quick Ratio | 3.11 | Shares Outstanding | 70.47M | 52W Low Chg | 160.00% |
Insider Own | - | ROA | -97.55% | Shares Float | - | Beta | 0.93 |
Inst Own | - | ROE | -233.54% | Shares Shorted/Prior | -/- | Price | 0.00260 |
Gross Margin | 51.97% | Profit Margin | - | Avg. Volume | 5,804 | Target Price | - |
Oper. Margin | -1,309.48% | Earnings Date | - | Volume | 100,000 | Change | 4.00% |
UMAX Group Corp., a development stage company, doing business as UMAX Nutrition, focuses on developing and distributing natural and organic nutrition, and dietary supplements to the nutritional industry. Its product line provides dietary needs for weight loss, colon health, sexual health, body building, and general health and vitality. The company's products include UPRITE XXL, a natural herbal male enhancement supplement providing an alternative to prescription erectile dysfunction medication; green coffee bean extract; and RASPBERRY KETONE, an anti-oxidant and fat burning ingredient. UMAX Group Corp. was founded in 2011 and is based in Los Angeles, California.